Correlation Between Revolution Medicines and Fate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Revolution Medicines and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revolution Medicines and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revolution Medicines and Fate Therapeutics, you can compare the effects of market volatilities on Revolution Medicines and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revolution Medicines with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revolution Medicines and Fate Therapeutics.
Diversification Opportunities for Revolution Medicines and Fate Therapeutics
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Revolution and Fate is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and Revolution Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revolution Medicines are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of Revolution Medicines i.e., Revolution Medicines and Fate Therapeutics go up and down completely randomly.
Pair Corralation between Revolution Medicines and Fate Therapeutics
Given the investment horizon of 90 days Revolution Medicines is expected to generate 0.34 times more return on investment than Fate Therapeutics. However, Revolution Medicines is 2.98 times less risky than Fate Therapeutics. It trades about -0.12 of its potential returns per unit of risk. Fate Therapeutics is currently generating about -0.23 per unit of risk. If you would invest 4,643 in Revolution Medicines on October 12, 2024 and sell it today you would lose (201.00) from holding Revolution Medicines or give up 4.33% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Revolution Medicines vs. Fate Therapeutics
Performance |
Timeline |
Revolution Medicines |
Fate Therapeutics |
Revolution Medicines and Fate Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Revolution Medicines and Fate Therapeutics
The main advantage of trading using opposite Revolution Medicines and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revolution Medicines position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.Revolution Medicines vs. Blueprint Medicines Corp | Revolution Medicines vs. Sana Biotechnology | Revolution Medicines vs. Kymera Therapeutics | Revolution Medicines vs. Monte Rosa Therapeutics |
Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |